News & Perspective

Nov 01, 2012

Nov 01, 2012

Fungal meningitis outbreak grows to 386 cases

(CIDRAP News) – Nine more patients have been sickened in a multistate fungal meningitis outbreak linked to a Massachusetts company's tainted steroid injections, boosting the total so far to 386, the US Centers for Disease Control and Prevention (CDC) said today.

Nov 01, 2012

Study: Rapid flu tests do best at high viral loads

(CIDRAP News) – Commercially available rapid influenza diagnostic tests (RIDTs) detected common virus strains at high concentrations fairly well but performed variably at lower concentrations, an evaluation of all 11 Food and Drug Administration–approved RIDTs showed.

Nov 02, 2012

Nov 02, 2012

BMJ renews pressure on Roche to release all Tamiflu trial data

(CIDRAP News) – The British journal BMJ this week renewed its campaign to persuade Roche to release unpublished clinical trial data on the flu drug oseltamivir (Tamiflu)—and used the occasion to announce that in the future it will publish only those drug trial reports whose sponsors agree to release all trial data when requested.

Nov 02, 2012

Nov 02, 2012

Bacteria found in two drugs as meningitis outbreak tops 400

(CIDRAP News) – Tests by federal health officials have detected bacterial contamination in two products from the Massachusetts compounding pharmacy linked to a multistate fungal meningitis outbreak caused by tainted steroid drugs, a finding that amplifies worries about the sterility of the company's products.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»